Evidence map›Paper›PMID 27046834›Full record

ArticleDevelopmental cell2016

An FGFR1-SPRY2 Signaling Axis Limits Basal Cell Proliferation in the Steady-State Airway Epithelium.

Gayan I Balasooriya, Jo-Anne Johnson, M Albert Basson, Emma L Rawlins

Open access · hybridAbstract read
In one paragraph

Article in Developmental cell, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. DNA methylation-mediatedFrontiers in molecular biosciences · 2024
    Article
  4. Review
  5. Review
  6. Journal of virology · 2022
    Article
  7. Review
  8. Review
  9. SARS-CoV-2 Infection and Lung Regeneration.Clinical microbiology reviews · 2022
    Review
  10. Article
  11. Article
  12. Genome-wide effect of pulmonary airway epithelial cell-specificFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Gayan I BalasooriyaWellcome Trust/CRUK Gurdon Institute, Wellcome Trust/MRC Stem Cell Institute, Department of Pathology, University of Cambridge, Cambridge CB2 1QN, UK.
Jo-Anne JohnsonWellcome Trust/CRUK Gurdon Institute, Wellcome Trust/MRC Stem Cell Institute, Department of Pathology, University of Cambridge, Cambridge CB2 1QN, UK.
M Albert BassonDepartment of Craniofacial Development and Stem Cell Biology, King's College London, London SE1 9RT, UK.
Emma L RawlinsWellcome Trust/CRUK Gurdon Institute, Wellcome Trust/MRC Stem Cell Institute, Department of Pathology, University of Cambridge, Cambridge CB2 1QN, UK. Electronic address: e.rawlins@gurdon.cam.ac.uk.
Wellcome Trust · GBKing's College London · GBWellcome/Cancer Research UK Gurdon Institute · GB

Funding

Cancer Research UK C6946/A14492Medical Research Council G0601104Medical Research Council G0900424Medical Research Council MC_PC_12009Wellcome Trust 092096
6 · The paper itself

Abstract

The steady-state airway epithelium has a low rate of stem cell turnover but can nevertheless mount a rapid proliferative response following injury. This suggests a mechanism to restrain proliferation at steady state. One such mechanism has been identified in skeletal muscle in which pro-proliferative FGFR1 signaling is antagonized by SPRY1 to maintain satellite cell quiescence. Surprisingly, we found that deletion of Fgfr1 or Spry2 in basal cells of the adult mouse trachea caused an increase in steady-state proliferation. We show that in airway basal cells, SPRY2 is post-translationally modified in response to FGFR1 signaling. This allows SPRY2 to inhibit intracellular signaling downstream of other receptor tyrosine kinases and restrain basal cell proliferation. An FGFR1-SPRY2 signaling axis has previously been characterized in cell lines in vitro. We now demonstrate an in vivo biological function of this interaction and thus identify an active signaling mechanism that maintains quiescence in the airway epithelium.

Indexed as

AnimalsCell ProliferationCells, CulturedEpithelial CellsEpitheliumFemaleIntracellular Signaling Peptides and ProteinsMaleMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutProtein Processing, Post-TranslationalProtein Serine-Threonine KinasesReceptor, Fibroblast Growth Factor, Type 1Respiratory MucosaFgfr1 protein, mouseIntracellular Signaling Peptides and ProteinsMembrane ProteinsProtein Serine-Threonine KinasesReceptor, Fibroblast Growth Factor, Type 1Spry2 protein, mouse

Identifiers

PMID27046834
PMCPMC4825408
OpenAlexW2293211337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.